Peptide Boom in the US: Bitcoin Becomes the Main Payment Tool of the Shadow Market
The American peptide market is experiencing unprecedented growth, with cryptocurrency playing a key role. In the first quarter of 2026, sellers of these drugs received $32 million in digital assets from buyers. This is 700% more than a year earlier. The market, which long remained in the shadows, has reached a new level, and bitcoin has become its primary payment instrument.
Why Peptides and Why Cryptocurrency?
Peptides are positioned as remedies for weight loss, muscle gain, and life extension. Legal drugs undergo clinical trials and are sold in major pharmacy chains such as Walgreens and CVS. However, a significant portion of online trade bypasses this system. Cheap analogs, often produced in foreign laboratories, are sold without a prescription or insurance. Many packages even bear a label stating they are not intended for human use.
Banks and payment systems refuse to service such sellers due to high compliance risks. As a result, many suppliers accept payment exclusively in bitcoin. For some buyers, this becomes their first experience using cryptocurrency. For example, a 49-year-old marketing director from the US, seeking retatrutide (an Eli Lilly drug), found a Chinese supplier who agreed to ship 20 vials for $240. On the American market, such a purchase would have cost him $300 per month. The seller only accepted cryptocurrency, and the buyer had to purchase bitcoin for the first time.
Stages of Growth: From the Underground to TikTok Subculture
Analysts identify three key stages in the development of this market. Before 2025, it was a niche "underground" with a monthly inflow of about $200,000. Then the topic came to the attention of the Make America Healthy Again movement, coinciding with the appointment of Robert F. Kennedy Jr. as head of the US Department of Health and Human Services. However, there is no direct causal link here.
The real explosion occurred in late 2025, when the peptide topic penetrated the TikTok subculture of looksmaxxing. Its followers are obsessed with improving their appearance and physical fitness. The average monthly inflow of cryptocurrency quadrupled to $9.9 million, and in peak months exceeded $10 million.
According to estimates from a former Coinbase employee, the annual turnover of the peptide market was about $100 million in 2023. In 2025, according to TRM Labs, digital asset inflows into the sector reached $41.4 million, up 20% from a year earlier. Experts compare the dynamics to the early stages of shadow online markets, such as Silk Road.
Major Players Shift to Stablecoins
The market is unevenly structured. The bulk of the volume comes from a narrow group of large sellers with a broad client base. Small players dabble in various coins, but large suppliers use almost exclusively bitcoin and stablecoins. Sellers with an average deposit of $1,000 or more prefer "stablecoins" — this hedges them against exchange rate fluctuations in large and cross-border purchases.
Chinese Raw Materials and Criminal Ties
The primary raw materials for peptides are produced in China. Chinese chemical manufacturers are actively expanding their presence in this niche. Over the first three quarters of last year, imports from China to the US doubled to over $300 million. Notably, some suppliers have transitioned to peptides from the drug business. For example, the Chinese company Bigreat Technology, which previously supplied precursors for fentanyl and amphetamines to the markets of Russia and Kazakhstan, has created a separate legal entity to sell cosmetic peptides.
Expert Commentary: This case demonstrates how cryptocurrency is becoming not just a speculative instrument but a real payment method for the shadow economy. A 700% growth in a year is not just a spike but the formation of a sustainable channel that will likely only expand. Regulators should pay close attention to this niche, as it is becoming increasingly professional and structured.